Dopavision is a therapeutic company developing a digital therapeutic for myopia.
Dopavision has raised €12M across 1 funding round from 3 investors, most recently a round in Jul 2021. Based in Berlin, Germany; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-07-14 | Other | €12M |
| Boehringer Ingelheim Venture Fund,Novartis Pharmaceuticals,Seventure Partners |
| View deal → |
